The field continues to witness landmark clinical and regulatory milestones—from approved therapies for retinal dystrophies and muscular atrophy to emerging treatments for hematological, oncological, and rare diseases.

Advances in precision gene editing, such as Prime Editing, base editing, and CRISPR-Cas12/Cas13 systems, are pushing the boundaries of what can be achieved at the genomic level. Likewise, cell-based therapeutics—including CAR-T cells, NK cell therapies, and engineered stem cells—are expanding their reach across a growing number of disease indications. These innovations represent the next era of personalized, high-precision medicine.

The conference will foster an integrated ecosystem of academia, biotech and pharma companies, regulatory agencies, healthcare providers, technology developers, and patient advocacy groups. Through strategic collaborations and knowledge exchange, these stakeholders are working collectively to overcome scientific, logistical, and regulatory barriers to advance the future of cell and gene therapy.

We warmly invite you to join the International Conference on Cell and Gene Therapy 2026 in Dubai. Engage with world-renowned experts, explore pioneering scientific achievements, and contribute to shaping the global landscape of advanced therapeutics.
Together, we can accelerate innovation, broaden accessibility, and build the future of transformative medicine.